Abstract
Nowadays, biodegradable nanoscale preparations such as liposomes, micelles, nanoparticles (NPs), and solid lipid nanoparticles (SLN) have attracted increasing attention from major researchers. Meanwhile the biosafety of the nanomaterials brings more and more attention. Toxicity of the biodegradable nanoscle preparations varies depending on their particle size, shape, surface structure, et al. This article aims to review the toxicity of the above-mentioned nanoscale preparations and the relative methodology. It may be significant for successful use of more nanoscale preparations in clinical practice.
Keywords: Liposomes, micelles, nanoparticles, PLGA, SLN, nanotoxicity
Current Drug Metabolism
Title:Toxicity of Biodegradable Nanoscale Preparations
Volume: 13 Issue: 4
Author(s): Fan Jian, Yi Zhang, Jing Wang, Kai Ba, Runyi Mao, Wenli Lai and Yunfeng Lin
Affiliation:
Keywords: Liposomes, micelles, nanoparticles, PLGA, SLN, nanotoxicity
Abstract: Nowadays, biodegradable nanoscale preparations such as liposomes, micelles, nanoparticles (NPs), and solid lipid nanoparticles (SLN) have attracted increasing attention from major researchers. Meanwhile the biosafety of the nanomaterials brings more and more attention. Toxicity of the biodegradable nanoscle preparations varies depending on their particle size, shape, surface structure, et al. This article aims to review the toxicity of the above-mentioned nanoscale preparations and the relative methodology. It may be significant for successful use of more nanoscale preparations in clinical practice.
Export Options
About this article
Cite this article as:
Jian Fan, Zhang Yi, Wang Jing, Ba Kai, Mao Runyi, Lai Wenli and Lin Yunfeng, Toxicity of Biodegradable Nanoscale Preparations, Current Drug Metabolism 2012; 13 (4) . https://dx.doi.org/10.2174/138920012800166517
DOI https://dx.doi.org/10.2174/138920012800166517 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in Pharmacokinetics of Polymeric Excipients Used in Nanosized Anti-Cancer Drugs
Current Drug Metabolism Potential for Predicting Toxicity and Response of Fluoropyrimidines in Patients
Current Drug Targets Angiotensin II: Role in Skeletal Muscle Atrophy
Current Protein & Peptide Science Cardioprotective Effects of the Polyphenol Hydroxytyrosol from Olive Oil
Current Drug Targets Magainin-Related Peptides Stimulate Insulin-Release and Improve Glucose Tolerance in High Fat Fed Mice
Protein & Peptide Letters Carbohydrate Microarray Technology for Functional Glycomics
Current Chemical Biology Plasma-Free Amino Acid Profiling of Nasal Polyposis Patients
Combinatorial Chemistry & High Throughput Screening Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
Current Medicinal Chemistry Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
Current Drug Metabolism The Dichloromethane Fraction of <i>Vernonia cinerea</i> Impart Pro-Apoptotic, Genotoxic, Cell Cycle Arrest, and Drug Efflux Inhibitory Effects on Human Adenocarcinoma Cells
Recent Patents on Anti-Cancer Drug Discovery Pharma-metabolomics in Neonatology: is it a Dream or a Fact?
Current Pharmaceutical Design UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6): Role in Cancer and Prospects as a Drug Target
Current Cancer Drug Targets Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine
Current Drug Metabolism GRP78 Influences Chemoresistance and Prognosis in Cancer
Current Drug Targets Nonviral Vectors for Cancer Gene Therapy: Prospects for Integrating Vectors and Combination Therapies
Current Gene Therapy Aging and DNA Methylation
Current Chemical Biology Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology Regulation of Mesenchymal Phenotype by MicroRNAs in Cancer
Current Cancer Drug Targets Targeting Telomerase by Antisense-Based Approaches: Perspectives for New Anti-Cancer Therapies
Current Pharmaceutical Design Chronopharmaceutical Delivery of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry